Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

T-cell responses as a correlate of COVID-19 vaccination. A pilot study in Health Care Workers

Mónica Martínez-Gallo, Juliana Esperalba-Esquerra, Ricardo Pujol-Borrell, Victor Sandá, Iria Arrese-Muñoz, Candela Fernández Naval, Andrés Antón Pagarolas, Victoria Cardona, Moisés Labrador-Horrillo, Tomás Pumarola-Suñé, Manuel Hernandéz-González
doi: https://doi.org/10.1101/2021.03.31.21254472
Mónica Martínez-Gallo
1Immunology Division, Hospital Universitari Vall d’Hebron (HUVH), Jeffrey Model Foundation Excellence Center. Barcelona, Catalonia, Spain
2Diagnostic Immunology research group Vall d’Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain
3Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB). Barcelona, Catalonia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juliana Esperalba-Esquerra
4Microbiology Division, Hospital Universitari Vall d’Hebron (HUVH). Departament de Genètica i Microbiologia. Autonomous University of Barcelona (UAB). Barcelona, Catalonia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ricardo Pujol-Borrell
1Immunology Division, Hospital Universitari Vall d’Hebron (HUVH), Jeffrey Model Foundation Excellence Center. Barcelona, Catalonia, Spain
2Diagnostic Immunology research group Vall d’Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain
3Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB). Barcelona, Catalonia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor Sandá
1Immunology Division, Hospital Universitari Vall d’Hebron (HUVH), Jeffrey Model Foundation Excellence Center. Barcelona, Catalonia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iria Arrese-Muñoz
1Immunology Division, Hospital Universitari Vall d’Hebron (HUVH), Jeffrey Model Foundation Excellence Center. Barcelona, Catalonia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Candela Fernández Naval
4Microbiology Division, Hospital Universitari Vall d’Hebron (HUVH). Departament de Genètica i Microbiologia. Autonomous University of Barcelona (UAB). Barcelona, Catalonia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrés Antón Pagarolas
4Microbiology Division, Hospital Universitari Vall d’Hebron (HUVH). Departament de Genètica i Microbiologia. Autonomous University of Barcelona (UAB). Barcelona, Catalonia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victoria Cardona
5Allergy Section, Internal Medicine Department. Hospital Universitari Vall d’Hebron (HUVH). Barcelona, Catalonia, Spain
6ARADyAL research network. Instituto de Salud Carlos III (ISCIII). Spain
7Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
8Universitat Autònoma de Barcelona (UAB). Barcelona. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moisés Labrador-Horrillo
5Allergy Section, Internal Medicine Department. Hospital Universitari Vall d’Hebron (HUVH). Barcelona, Catalonia, Spain
6ARADyAL research network. Instituto de Salud Carlos III (ISCIII). Spain
7Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
8Universitat Autònoma de Barcelona (UAB). Barcelona. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mlabrador@vhebron.net
Tomás Pumarola-Suñé
4Microbiology Division, Hospital Universitari Vall d’Hebron (HUVH). Departament de Genètica i Microbiologia. Autonomous University of Barcelona (UAB). Barcelona, Catalonia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Hernandéz-González
1Immunology Division, Hospital Universitari Vall d’Hebron (HUVH), Jeffrey Model Foundation Excellence Center. Barcelona, Catalonia, Spain
2Diagnostic Immunology research group Vall d’Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain
3Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB). Barcelona, Catalonia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Clinical trials on the different vaccines to SARS-CoV-2 have demonstrated protection efficacy, but it is urgent to assess the levels of protection generated with real-world data, especially in individuals professionally exposed. Measuring T-cell responses may complement antibody tests currently in use as correlates of protection but there are not validated T cell response applicable to large number of samples.

Objective To assess the feasibility of using T-cell responses to SARS-CoV-2 S peptides by commercially available whole blood interferon-gamma release assays (IGRA) as a correlate of protection.

Patients Twenty health care workers before and after vaccination.

Methods Antibody test to SARS-CoV-2 N and S proteins in parallel with one IGRA assay and two detection techniques than can be automated.

Results IGRA test detected T-cell responses in naturally exposed and vaccinated HCW already after first vaccination dose. the correlation by the two detection methods, CLIA and ELISA, very high (R>0.9) and sensitivity and specificity ranged between 100 and 86% and 100-73% respectively. Even though there was a very high concordance between antibody and the IGRA assay in the ability to detect immune response to SARS-CoV-2 there was a relatively low quantitative correlation. In the small group primed by natural infection, one vaccine dose was sufficient to reach immune response plateau. IGRA was positive in one Ig (S) antibody negative vaccinated immunosuppressed HCW illustrating another advantage of the IGRA test.

Conclusion Whole blood IGRA tests amenable to automation, as the one here reported, constitute a promising additional tool for measuring the state of the immune response to SARS-CoV-2; they are applicable to large number of samples and may become valuable correlates of protection to COVID-19, particularly for vulnerable groups at risk of being re-exposed to infection, as are health care workers.

Clinical Implications Commercial kits of whole blood Interferon-gamma release assay (IGRA) constitute an reliable method for clinical laboratories to assess T-cell response after natural infection by SARS-CoV-2 and after BNT162b2 mRNA vaccination and are suitable for large scale application.

Key Messages

  • Commercial kits of whole blood interferon-gamma release assay (IGRA) are potentially very useful tools to measure the T cell response to SARS-CoV-2 after COVID-19 and after SARS-CoV-2 vaccination.

  • One vaccine dose restores T cell response in COVID recovered patients, but the vaccination boost was required for naïve participants to attain a comparable response.

  • T cell response seem to decay in COVID recovered subjects after the boost second vaccination dose.

Capsule Summary Measuring T cell responses by commercially available whole blood interferon gamma release assays (IGRA) provide a promising additional correlate of protection to COVID and may be useful to reassure vulnerable group professionals at risk of being exposed to SARS-CoV-2 infection.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded in part by Instituto de Salud Carlos III, grant COV20/00416 co-financed by the European Regional Development Fund (ERDF).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This project was approved by the Hospital Universitari Vall d,Hebron Institutional Clinical Ethical Board. (HUVH PR(AG)113/2021).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

27-March-2021

  • Abbreviations

    (HCWs)
    Health care workers
    (IGRA)
    Interferon-gamma release assays
    (CLIA)
    Chemiluminescence immunoassays
    (ELISA)
    Enzyme linked immunosorbent assay
    (CBC)
    Complete blood count
    (S)
    Spike protein
    (N)
    Nucleocapsid protein
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted April 05, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    T-cell responses as a correlate of COVID-19 vaccination. A pilot study in Health Care Workers
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    T-cell responses as a correlate of COVID-19 vaccination. A pilot study in Health Care Workers
    Mónica Martínez-Gallo, Juliana Esperalba-Esquerra, Ricardo Pujol-Borrell, Victor Sandá, Iria Arrese-Muñoz, Candela Fernández Naval, Andrés Antón Pagarolas, Victoria Cardona, Moisés Labrador-Horrillo, Tomás Pumarola-Suñé, Manuel Hernandéz-González
    medRxiv 2021.03.31.21254472; doi: https://doi.org/10.1101/2021.03.31.21254472
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    T-cell responses as a correlate of COVID-19 vaccination. A pilot study in Health Care Workers
    Mónica Martínez-Gallo, Juliana Esperalba-Esquerra, Ricardo Pujol-Borrell, Victor Sandá, Iria Arrese-Muñoz, Candela Fernández Naval, Andrés Antón Pagarolas, Victoria Cardona, Moisés Labrador-Horrillo, Tomás Pumarola-Suñé, Manuel Hernandéz-González
    medRxiv 2021.03.31.21254472; doi: https://doi.org/10.1101/2021.03.31.21254472

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Allergy and Immunology
    Subject Areas
    All Articles
    • Addiction Medicine (174)
    • Allergy and Immunology (419)
    • Anesthesia (97)
    • Cardiovascular Medicine (894)
    • Dentistry and Oral Medicine (166)
    • Dermatology (101)
    • Emergency Medicine (257)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (404)
    • Epidemiology (8744)
    • Forensic Medicine (4)
    • Gastroenterology (403)
    • Genetic and Genomic Medicine (1844)
    • Geriatric Medicine (175)
    • Health Economics (386)
    • Health Informatics (1281)
    • Health Policy (642)
    • Health Systems and Quality Improvement (488)
    • Hematology (206)
    • HIV/AIDS (387)
    • Infectious Diseases (except HIV/AIDS) (10519)
    • Intensive Care and Critical Care Medicine (564)
    • Medical Education (193)
    • Medical Ethics (52)
    • Nephrology (216)
    • Neurology (1744)
    • Nursing (100)
    • Nutrition (264)
    • Obstetrics and Gynecology (342)
    • Occupational and Environmental Health (457)
    • Oncology (959)
    • Ophthalmology (279)
    • Orthopedics (107)
    • Otolaryngology (174)
    • Pain Medicine (117)
    • Palliative Medicine (41)
    • Pathology (262)
    • Pediatrics (553)
    • Pharmacology and Therapeutics (264)
    • Primary Care Research (218)
    • Psychiatry and Clinical Psychology (1836)
    • Public and Global Health (3962)
    • Radiology and Imaging (649)
    • Rehabilitation Medicine and Physical Therapy (340)
    • Respiratory Medicine (532)
    • Rheumatology (214)
    • Sexual and Reproductive Health (178)
    • Sports Medicine (165)
    • Surgery (196)
    • Toxicology (37)
    • Transplantation (105)
    • Urology (78)